Literature DB >> 8522938

A scale for assessing the stage of substance abuse treatment in persons with severe mental illness.

G J McHugo1, R E Drake, H L Burton, T H Ackerson.   

Abstract

Substance abuse is common among persons with severe mental illness, but few measures exist for clinicians to evaluate treatment progress. The Substance Abuse Treatment Scale (SATS) combines a motivational hierarchy with explicit substance use criteria to form an eight-stage model of the recovery process. Data are presented supporting the reliability and validity of the SATS, based on its use in a community-based sample of persons with dual disorders. The SATS can be used as either a process or an outcome measure, for individuals or for groups, and its value in making explicit the stages of substance abuse treatment is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 8522938     DOI: 10.1097/00005053-199512000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  33 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Intensive case management for severe mental illness.

Authors:  Marina Dieterich; Claire B Irving; Bert Park; Max Marshall
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

3.  Use of the Transtheoretical Model for individuals with co-occurring disorders.

Authors:  Deborah S Finnell
Journal:  Community Ment Health J       Date:  2003-02

4.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 5.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

6.  Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes.

Authors:  Gary A Morse; Robert J Calsyn; W Dean Klinkenberg; Thomas W Helminiak; Nancy Wolff; Robert E Drake; Robert D Yonker; Gyanesh Lama; Matthew R Lemming; Suzanne McCudden
Journal:  Community Ment Health J       Date:  2006-08-04

7.  Measuring illness management outcomes: a psychometric study of clinician and consumer rating scales for illness self management and recovery.

Authors:  Michelle P Salyers; Jenna L Godfrey; Kim T Mueser; Shauna Labriola
Journal:  Community Ment Health J       Date:  2007-05-21

Review 8.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

9.  A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.

Authors:  Mary F Brunette; Ree Dawson; Christopher D O'Keefe; Meera Narasimhan; Douglas L Noordsy; Joanne Wojcik; Alan I Green
Journal:  J Dual Diagn       Date:  2011

10.  Fidelity and outcomes in six integrated dual disorders treatment programs.

Authors:  Daniel W Chandler
Journal:  Community Ment Health J       Date:  2009-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.